A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(31 sites)

Argentina

Investigational Site Number : 0320004, San Miguel de Tucumán, Tucumán Province

Investigational Site Number : 0320005, Buenos Aires

Canada

Investigational Site Number : 1240110, Calgary, Alberta

Finland

Investigational Site Number : 2460040, Helsinki

France

Investigational Site Number : 2500041, Bron